←
Chan Ho Lim552 posts
Chan Ho Lim avatar

Chan Ho Lim

@chanholim

Assistant director of Digital Health for Tulane Research Innovation for Arrhythmia Discovery (TRIAD)

◷ Joined February 2021▧ 27 Photos and videos
David Ouyang, MD avatar
⟳ Chan Ho Lim retweeted
David Ouyang, MD@David_Ouyang·Nov 9

1/n Excited to share AI ECHO INSIGHT, the first blinded, randomized trial of AI for the full echo report, presented today by Keane Lee at #ScientificSessions26 Late-Breaking Science. EchoPrime and EchoNet-Measurements drafted the interpretations and measurements for cardiologist review. #echofirst

0:29
Nassir Marrouche avatar
⟳ Chan Ho Lim retweeted
Nassir Marrouche@nmarrouche·Oct 31

Proud of @MekhaelMario for leading this DECAAF-II analysis! Our findings echo @peterkistler3’s work on AF burden, with an important distinction: LA volume also independently predicted arrhythmia recurrence after PVI. LA enlargement offers a window into atrial remodeling. In our cohort, larger atria had more fibrosis, suggesting more advanced structural disease—a substrate that may sustain #AFib despite #PVI Understanding the underlying atrial disease is central to understanding ablation outcomes. Actual current priority focus of @TulaneHeart and @TulaneTriad @Phiso_de @chris_sohns @PrashSanders @gautamsand @S_NarayanMD @TinaBaykaner @Siddmann @drjohnm

Very interesting study! We found quite similar findings in our DECAAF-II subanalysis, where LA volume and AF burden were correlated with a similar R² of 0.12. However, we also found a significant difference in AF recurrence rates between patients with low versus high LA volumes.

Post attachment
Yara Menassa avatar
⟳ Chan Ho Lim retweeted
Yara Menassa@YaraMenassa·Sep 26

Been working my whole life for this moment; officially applied to General Surgery residency! #Match2027 From graduating from @AUBMC_Official to my current postdoctoral research fellowship @Tulane, I’m excited to take the next step toward becoming a surgeon-scientist. Incredibly grateful to everyone who has supported and guided me along the way. Looking forward to connecting with colleagues and programs throughout the interview season! #MedTwitter #GeneralSurgery AAMC ID: 14997886

Post attachment
Michel Abou Khalil avatar
⟳ Chan Ho Lim retweeted
Michel Abou Khalil@mabou_khalil·Sep 16

AF recurs in up to 50% post-ablation, what's next is often just operator preference. Our study in Europace of 3,100+ patients: redo ablation cut death/stroke/HF by 35% vs. cardioversion (NNT=14). 🫀⚡ @nmarrouche @HanFengGHD @QMarashly 📄 doi.org/10.1093/europace/eua… #AFib #EPeeps

Ghassan Bidaoui avatar
⟳ Chan Ho Lim retweeted
Ghassan Bidaoui@BidaouiGhassan·Aug 23

Excited to share that the HEARTBEAT study design is out! Let’s see where PPG assessment in a real-world setting can lead us to in Cardiovascular medicine! @nmarrouche @MassadChristian @HanFengGHD @chanholim @AlaAssaf3 @BsoulMayana @TulaneTriad @QMarashly academic.oup.com/ehjdh/advan…

Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Apr 25

Excellent work from @MassadChristian and the team! Extra-PV ablation using the VARIPULSE catheter appears to be safe and effective, with high success rates and a favorable complication profile during medium- to long-term follow-up. Exciting progress in AF ablation strategies.

Post attachment
Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Apr 13

Huge congratulations to @YingshuoL, our AI leader at TRIAD, for presenting the team’s work and vision for AI in cardiology at Grand Rounds at Tulane School of Medicine! Exciting to see how AI is transforming both research and clinical care in arrhythmia at Tulane.

Post attachmentPost attachmentPost attachmentPost attachment
Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Mar 29

Congrats to @mabou_khalil Great work from HEARTBEAT study, a prospective smartwatch cohort in Louisiana with high cardiovascular risk. Lower income was associated with greater comorbidity burden and higher risk of death, stroke, or hospitalizations. More to come. #ACC26

Post attachment
Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Mar 28

Congrats to Dr.@BsoulMayana on her impactful work 👏 AF patients treated with amiodarone show higher mortality risk, consistent across CHA₂DS₂-VASc strata (≥2 and <2). Important signal that risk persists regardless of baseline stroke risk. #ACC26 @TulaneDDoM @TulaneTriad

Post attachment
Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Mar 29

Great session on AI in cardiology. Thank you @lamcardio and Dr. Seinath Adusumalli for putting it together! Incredible insights from @rohan_khera and @zachia5 on translating AI into clinical practice and trials at Yale and Mayo Clinic. Excited about the future medicine. #ACC26

Post attachment
Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Mar 1

My most favorite session at #WesternAFib. Since I first attended, @netta_doc always follows every session and gives the final wrap-up with highlights of the whole symposium. Refreshes all the remaining controversial topics and makes me think deeper every time. Really grateful 🙏

Post attachment
Han Feng avatar
⟳ Chan Ho Lim retweeted
Han Feng@HanFengGHD·Feb 24

Congratulations to @montaser4k and @QMarashly on this outstanding work. 🎉 Concomitant PFA + LAAO may represent a safer, streamlined strategy for AF patients: • Lower leak
• Shorter procedure
• Comparable complications/recurrence Read more: onlinelibrary.wiley.com/doi/… #AF #PFA